Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 389


Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.

Zou X, Feng B, Dong T, Yan G, Tan B, Shen H, Huang A, Zhang X, Zhang M, Yang P, Zheng M, Zhang Y.

J Proteomics. 2013 Dec 6;94:473-85. doi: 10.1016/j.jprot.2013.10.020. Epub 2013 Oct 24.


Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC).

Hammoudi A, Song F, Reed KR, Jenkins RE, Meniel VS, Watson AJ, Pritchard DM, Clarke AR, Jenkins JR.

Biochem Biophys Res Commun. 2013 Oct 25;440(3):364-70. doi: 10.1016/j.bbrc.2013.08.076. Epub 2013 Aug 31.


An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.

Han CL, Chen JS, Chan EC, Wu CP, Yu KH, Chen KT, Tsou CC, Tsai CF, Chien CW, Kuo YB, Lin PY, Yu JS, Hsueh C, Chen MC, Chan CC, Chang YS, Chen YJ.

Mol Cell Proteomics. 2011 Apr;10(4):M110.003087. doi: 10.1074/mcp.M110.003087. Epub 2011 Jan 5.


Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis.

Sethi MK, Thaysen-Andersen M, Kim H, Park CK, Baker MS, Packer NH, Paik YK, Hancock WS, Fanayan S.

J Proteomics. 2015 Aug 3;126:54-67. doi: 10.1016/j.jprot.2015.05.037. Epub 2015 Jun 6.


New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer.

Peng Y, Li X, Wu M, Yang J, Liu M, Zhang W, Xiang B, Wang X, Li X, Li G, Shen S.

Mol Biosyst. 2012 Nov;8(11):3077-88. doi: 10.1039/c2mb25286d. Epub 2012 Sep 20.


Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.

Shin J, Kim HJ, Kim G, Song M, Woo SJ, Lee ST, Kim H, Lee C.

J Proteome Res. 2014 Nov 7;13(11):4919-31. doi: 10.1021/pr500790f. Epub 2014 Sep 23.


Identification of Cystatin SN as a novel tumor marker for colorectal cancer.

Yoneda K, Iida H, Endo H, Hosono K, Akiyama T, Takahashi H, Inamori M, Abe Y, Yoneda M, Fujita K, Kato S, Nozaki Y, Ichikawa Y, Uozaki H, Fukayama M, Shimamura T, Kodama T, Aburatani H, Miyazawa C, Ishii K, Hosomi N, Sagara M, Takahashi M, Ike H, Saito H, Kusakabe A, Nakajima A.

Int J Oncol. 2009 Jul;35(1):33-40.


Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.

Ma YL, Peng JY, Zhang P, Huang L, Liu WJ, Shen TY, Chen HQ, Zhou YK, Zhang M, Chu ZX, Qin HL.

J Proteome Res. 2009 Oct;8(10):4525-35. doi: 10.1021/pr900365e.


Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.

Ma Y, Peng J, Liu W, Zhang P, Huang L, Gao B, Shen T, Zhou Y, Chen H, Chu Z, Zhang M, Qin H.

Mol Cell Proteomics. 2009 Aug;8(8):1878-90. doi: 10.1074/mcp.M800541-MCP200. Epub 2009 May 20.


A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.

Peng J, Zhang Q, Ma Y, Wang Y, Huang L, Zhang P, Chen J, Qin H.

Electrophoresis. 2009 Sep;30(17):2976-87. doi: 10.1002/elps.200900203.


Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.

Shi H, Zhou Y, Liu H, Chen C, Li S, Li N, Li X, Zhang X, Zhang H, Wang W, Zhao Q.

BMC Cancer. 2010 Sep 3;10:477. doi: 10.1186/1471-2407-10-477.


Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.

Toiyama Y, Hur K, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A.

Ann Surg. 2014 Apr;259(4):735-43. doi: 10.1097/SLA.0b013e3182a6909d.


Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.

Zhang J, Song MQ, Zhu JS, Zhou Z, Xu ZP, Chen WX, Chen NW.

Int J Immunopathol Pharmacol. 2011 Oct-Dec;24(4):849-59.


Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma.

Wang XQ, Tang ZX, Yu D, Cui SJ, Jiang YH, Zhang Q, Wang J, Yang PY, Liu F.

Oncotarget. 2016 Feb 23;7(8):8823-38. doi: 10.18632/oncotarget.6815.


Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues.

Yao L, Lao W, Zhang Y, Tang X, Hu X, He C, Hu X, Xu LX.

J Proteome Res. 2012 Jun 1;11(6):3281-94. doi: 10.1021/pr300020p. Epub 2012 Apr 30.


Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.

Zhang Q, Wang XQ, Wang J, Cui SJ, Lou XM, Yan B, Qiao J, Jiang YH, Zhang LJ, Yang PY, Liu F.

Oncotarget. 2015 Jun 20;6(17):15095-110.


Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.

Wang H, Zhang X, Wang L, Zheng G, Du L, Yang Y, Dong Z, Liu Y, Qu A, Wang C.

J Surg Oncol. 2014 May;109(6):574-9. doi: 10.1002/jso.23526. Epub 2013 Dec 11.


Discovery of potential colorectal cancer serum biomarkers through quantitative proteomics on the colonic tissue interstitial fluids from the AOM-DSS mouse model.

Wang Y, Shan Q, Hou G, Zhang J, Bai J, Lv X, Xie Y, Zhu H, Su S, Li Y, Zi J, Lin L, Han W, Zhao X, Wang H, Xu N, Wu L, Lou X, Liu S.

J Proteomics. 2016 Jan 30;132:31-40. doi: 10.1016/j.jprot.2015.11.013. Epub 2015 Nov 12.


Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.

Gao JY, Song BR, Peng JJ, Lu YM.

World J Gastroenterol. 2012 Nov 7;18(41):5965-71. doi: 10.3748/wjg.v18.i41.5965.


Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.

Feng B, Xu WB, Zheng MH, Ma JJ, Cai Q, Zhang Y, Ji J, Lu AG, Qu Y, Li JW, Wang ML, Hu WG, Liu BY, Zhu ZG.

J Gastroenterol Hepatol. 2006 Oct;21(10):1596-603.


Supplemental Content

Support Center